These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The COPD Pipeline XVII. Gross N COPD; 2012 Aug; 9(4):432-4. PubMed ID: 22734623 [No Abstract] [Full Text] [Related]
5. Tumor necrosis factor inhibitors for rheumatoid arthritis. Dentener MA; Wouters EF N Engl J Med; 2006 Nov; 355(19):2047-8; author reply 2048. PubMed ID: 17099951 [No Abstract] [Full Text] [Related]
6. Perspectives for cytokine antagonist therapy in COPD. de Boer WI Drug Discov Today; 2005 Jan; 10(2):93-106. PubMed ID: 15718158 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacological treatment of COPD and future of anti-inflammatory therapy]. Watz H; Bitter-Suermann S; Kanniess F; Magnussen H Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484 [TBL] [Abstract][Full Text] [Related]
8. The COPD Pipeline XIV. Gross NJ COPD; 2012 Feb; 9(1):81-3. PubMed ID: 22292600 [No Abstract] [Full Text] [Related]
9. Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. Barnes PJ Am J Respir Crit Care Med; 2007 May; 175(9):866-7. PubMed ID: 17446342 [No Abstract] [Full Text] [Related]
10. The COPD pipeline IV. Gross NJ COPD; 2010 Jun; 7(3):229-31. PubMed ID: 20486822 [No Abstract] [Full Text] [Related]
11. Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease. Wang YH; Bai CX; Hong QY; Chen J Acta Pharmacol Sin; 2003 Dec; 24(12):1324-7. PubMed ID: 14653967 [TBL] [Abstract][Full Text] [Related]
12. The COPD pipeline XX. Gross N COPD; 2013 Feb; 10(1):104-6. PubMed ID: 23413896 [No Abstract] [Full Text] [Related]
14. Challenges in targeting TNF alpha in asthma and COPD. Antoniu SA Curr Opin Investig Drugs; 2009 May; 10(5):404-6. PubMed ID: 19431072 [No Abstract] [Full Text] [Related]
15. The COPD Pipeline IX. Gross NJ COPD; 2011 Apr; 8(2):136-8. PubMed ID: 21495841 [No Abstract] [Full Text] [Related]
16. [The effects of recombinant human tumor necrosis factor-Fc on pulmonary function in a rat model of chronic obstructive pulmonary disease]. Zhang C; Chen P; Cai S; Chen JB; Wu J Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):432-6. PubMed ID: 17673016 [TBL] [Abstract][Full Text] [Related]
17. New treatments for chronic obstructive pulmonary disease. Barnes PJ Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577 [TBL] [Abstract][Full Text] [Related]
18. The traditional herbal medicine Hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease. Shinozuka N; Tatsumi K; Nakamura A; Terada J; Kuriyama T J Am Geriatr Soc; 2007 Feb; 55(2):313-4. PubMed ID: 17302677 [No Abstract] [Full Text] [Related]
19. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development. Fitzgerald MF; Fox JC Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533 [TBL] [Abstract][Full Text] [Related]